NEW YORK, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inves

Rafael NYSE: RFL reported top-line results from its pivotal Phase III TransportNPC study evaluating

Aetna 2027 Medicare plans offer reliable, affordable access to care and member supportPR NewswireWOO

U.S. stocks mixed: Dow fell over 200 points, while Nasdaq and S&P 500 rose; inflation cooled and

Rafael Holdings (NYSE: RFL) stock tumbles after its Phase 3 TransportNPC study of Trappsol Cyclo mis

Gainers NewGenIvf Group (NASDAQ:NIVF) shares moved upwards by 147.1% to $0.18 during Wednesday'

Rafael Holdings, Inc. (RFL) Discusses Topline Results of Phase III TransportNPC Study of Trappsol Cy

U.S. stocks rose, led by tech, as Jabil beat Q4 estimates and raised FY2027 guidance; oil and gold a

Gainers NewGenIvf Group (NASDAQ:NIVF) shares moved upwards by 106.0% to $0.15 during Wednesday'

Trappsol® Cyclo™ was well tolerated and demonstrated a directionally favorable treatment effect on t

Trappsol ® Cyclo™ did not achieve statistical significance but demonstrated a directionally favorabl

Gainers Quoin Pharmaceuticals (NASDAQ:QNRX) shares rose 24.6% to $6.42 during Friday's regular

The MOU supports exploration of a nuclear test reactor site at the Utah San Rafael Energy Lab to adv

Rafael (NYSE: RFL - Get Free Report) and Oncology Pharma (OTCMKTS:ONPH - Get Free Report) are both s

72% of Drilled Holes Return Uranium Mineralization; 3D Drill Targets Generated Across Historical Uta

Gainers OSR Health (NASDAQ:OSRH) stock increased by 7.2% to $0.33 during Wednesday's after-mark

Former SOCOM Senior Technical Advisor to CIO/J6 and Executive Communications Chief to Guide Sekur's

Highly accomplished executive with extensive exploration, strategy, corporate development and capita

Rafael Holdings' Phase 3 clinical trial of a drug named Trappsol Cyclo just got over. Results of the

Dutch beer maker Heineken has appointed Rafael Oliveira as its new chair and CEO, it ​said on Tuesda

Amsterdam, 23 June 2026 Heineken N.V. announces nomination of Rafael Oliveira as Chief Executive Off

Rafael Holdings (NYSE:RFL) reported quarterly losses of $(0.08) per share. This is a 57.89 percent i

NEWARK, N.J., June 11, 2026 (GLOBE NEWSWIRE) -- Rafael Holdings, Inc. (NYSE: RFL) today reported its

The company has had a pre-NDA meeting with the FDA and expects to submit an NDA in second half of ca

Topline results are expected to be announced in second half of calendar 2026 The company has had a p

Rafael Holdings, Inc. (NYSE:RFL) today announced that its subsidiary, Cyclo Therapeutics, has entere

License of the MIT patent strengthens Rafael's intellectual property around cyclodextrins as an Acti

Elite Pharmaceuticals (OTCMKTS:ELTP - Get Free Report) and Rafael (NYSE: RFL - Get Free Report) are

Transaction creates global coffee powerhouse  Oliveira will continue as JDE Peet's CEO and joins KDP

Transaction creates global coffee powerhouse Oliveira will continue as JDE Peet's CEO and joins KDP

Rafael Holdings (NYSE:RFL) reported quarterly losses of $(0.13) per share. This is a 31.58 percent i

NEWARK, N.J., March 16, 2026 (GLOBE NEWSWIRE) -- Rafael Holdings, Inc. (NYSE: RFL) today reported it

Rafael Holdings (NYSE:RFL) reported quarterly losses of $(0.19) per share. This is a 86.03 percent i

Rafael Holdings, Inc. (NYSE:RFL, NYSE:RFL) today provided an update to the subscription rights relat

Rafael Holdings, Inc. (NYSE:RFL, NYSE:RFL) today announced revised subscription rights in connection